Specialized heart failure centers--a success or an indicator of the failure of our health care delivery system.
作者信息
Pitt B, Nicklas J M
出版信息
Clin Cardiol. 2000 Dec;23(12):881-2. doi: 10.1002/clc.4960231204.
Abstract
摘要
相似文献
1
Specialized heart failure centers--a success or an indicator of the failure of our health care delivery system.专业心力衰竭中心——是成功之举还是我们医疗服务体系失败的标志。
Clin Cardiol. 2000 Dec;23(12):881-2. doi: 10.1002/clc.4960231204.
2
Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure.心力衰竭项目对慢性心力衰竭患者心血管药物使用及剂量的影响。
Clin Cardiol. 2000 Dec;23(12):909-14. doi: 10.1002/clc.4960231211.
3
Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?心力衰竭与血管紧张素转换酶抑制剂。是否需要专科护理？
J Gen Intern Med. 1997 Sep;12(9):581-2. doi: 10.1046/j.1525-1497.1997.07147.x.
4
Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.欧洲心脏病学会指南对 22476 例荷兰心力衰竭住院患者出院后药物治疗方案的影响：2001 年至 2015 年。
Heart Fail Rev. 2019 Jul;24(4):499-510. doi: 10.1007/s10741-019-09777-2.
5
Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.解释血管紧张素转换酶抑制剂在心力衰竭治疗中使用情况的医生、组织和患者特征：一项多层次研究。
Eur J Clin Pharmacol. 2005 Apr;61(2):145-51. doi: 10.1007/s00228-005-0897-6. Epub 2005 Mar 11.
6
Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.基于证据的心力衰竭药物治疗的处方模式和 ASIAN-HF 注册研究的结果：一项队列研究。
Lancet Glob Health. 2018 Sep;6(9):e1008-e1018. doi: 10.1016/S2214-109X(18)30306-1.
7
General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.全科医生对慢性心力衰竭药物治疗指南的遵循情况：全科医生-心力衰竭研究
Clin Res Cardiol. 2016 May;105(5):441-50. doi: 10.1007/s00392-015-0939-8. Epub 2015 Nov 9.
8
Outpatient management of heart failure in the United States, 2006-2008.2006 - 2008年美国心力衰竭的门诊管理
Tex Heart Inst J. 2014 Jun 1;41(3):253-61. doi: 10.14503/THIJ-12-2947. eCollection 2014 Jun.
9
A taxonomy of reasons for not prescribing guideline-recommended medications for patients with heart failure.心力衰竭患者未开具指南推荐药物的原因分类
Am J Geriatr Pharmacother. 2010 Dec;8(6):583-94. doi: 10.1016/S1543-5946(10)80007-8.
10
Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction?心力衰竭的存在是否会改变心肌梗死后药物治疗的处方？
Med J Aust. 2007 Jan 15;186(2):99-100; author reply 100-101. doi: 10.5694/j.1326-5377.2007.tb00817.x.
本文引用的文献
1
Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure.心力衰竭项目对慢性心力衰竭患者心血管药物使用及剂量的影响。
Clin Cardiol. 2000 Dec;23(12):909-14. doi: 10.1002/clc.4960231211.
2
Effect of a heart failure program on hospitalization frequency and exercise tolerance.心力衰竭项目对住院频率和运动耐量的影响。
Circulation. 1997 Nov 4;96(9):2842-8. doi: 10.1161/01.cir.96.9.2842.
3
A case manager intervention to reduce readmissions.一项旨在减少再入院的病例管理干预措施。
Arch Intern Med. 1994 Aug 8;154(15):1721-9.
4
Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure.强化家庭护理监测可预防老年重症充血性心力衰竭患者住院，并改善其发病率。
Am Heart J. 1995 Apr;129(4):762-6. doi: 10.1016/0002-8703(95)90327-5.
5
A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure.一项预防老年充血性心力衰竭患者再入院的多学科干预措施。
N Engl J Med. 1995 Nov 2;333(18):1190-5. doi: 10.1056/NEJM199511023331806.
Zotero 插件